Skip to main content
Stephen Boorjian, MD, Urology, Rochester, MN

StephenAnthonyBoorjianMD

Urology Rochester, MN

Professor of Urology, Vice Chair of Research for the Department of Urology, and the Director of the Urologic Oncology Fellowship at Mayo Clinic, Rochester, MN.

Dr. Boorjian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Boorjian's full profile

Already have an account?

  • Office

    200 1st St SW
    Rochester, MN 55905
    Phone+1 507-284-2511
    Fax+1 507-284-0161

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2002 - 2006
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2000 - 2002
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 2022 - 2026
  • IL State Medical License
    IL State Medical License 2022 - 2026
  • ND State Medical License
    ND State Medical License 2022 - 2026
  • MN State Medical License
    MN State Medical License 2010 - 2025
  • WI State Medical License
    WI State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2008 - 2010
  • NY State Medical License
    NY State Medical License 2001 - 2009
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Young Urologist of the Year American Urological Association, 2014
  • AUA-EAU Academic Exchange Program Scholar 2014
  • Teacher of the Year Department of Urology, Mayo Clinic Fellows' Association, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma  
    Boris Gershman, Stephen A Boorjian, Bradley C Leibovich, European Urology
  • The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment  
    Bimal Bhindi, Igor Frank, Aaron M Potretzke, Stephen A Boorjian, John C Cheville, Bradley C Leibovich, European Urology
  • Temporal Trends in Venous Thromboembolism After Radical Cystectomy☆  
    Matthew K Tollefson, Igor Frank, Stephen A Boorjian, Urologic Oncology

Authored Content

  • A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsMay 2018
  • Predicting Oncologic Outcomes in Renal Cell Carcinoma After SurgeryFebruary 2018
  • Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-Term Results from a Large, Multi-Institutional SeriesDecember 2017

Press Mentions

  • FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer
    FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder CancerDecember 16th, 2022
  • Clinical Trials for Bladder Cancer
    Clinical Trials for Bladder CancerSeptember 3rd, 2022
  • Clinical Trials for Bladder Cancer
    Clinical Trials for Bladder CancerSeptember 1st, 2022
  • Join now to see all

Committees

  • Member, National Comprehensive Cancer Network Guideline Panel: Bladder Cancer/Penile Cancer 2014 - Present

Professional Memberships